Cisplatin

Intervention

200 papers mention it13 findings

PubChemMeSH

Research on it is growing 25% slower than aging research as a whole: 46 papers in the latest year counted

11 new papers in 30 daysSee all 200 papers on cisplatin

At a glance

The findings reach people, from one lab or study; independent labs found the same change in cells. 9 independent labs in 5 countries; 2,231 trials, 789 with no results posted.

“For the whole group (n = 55), TL did not change 1 year after CT (5.7 (2.2-13.4) vs. 5.8 kb (1.6-19.2), P = 0.335).”
Change in telomere length and cardiovascular risk factors in testicular cancer survivorsUrologic oncology2023doi:10.1016/j.urolonc.2023.10.010

None of its findings points the other way.

Cells: replicated by independent labs. Mice and humans: a single group. Worms or flies: nothing yet.
  • 9 independent labs in 5 countries
  • 2,231 trials, 789 with no results posted
  • Funders: Bayer Yakuhin and others
  • 4 of 13 findings with company ties
  • 3 of 2,231 trials sponsored by its developers

What did studies of cisplatin find?

9

Studies of cisplatin measured 9 outcomes; the most studied is cellular senescence (3 studies).

Cellular senescence

upin human cells2upin rat cells1

3 studies
  1. Cisplatin induces cellular senescence in human small intestinal organoids.

    Cellsin human small intestinal organoids

  2. Cisplatin induces cellular senescence in human cells (repeated treatment).

    Cellsrepeated treatment

  3. Cisplatin induces cellular senescence in NRK-49F rat kidney fibroblasts.

    Cellsin NRK-49F rat kidney fibroblastskidney

More on Cellular senescence

p53–p21 pathway

upin human cells1

1 study
  1. Cisplatin activates p53–p21 pathway in human small intestinal organoids.

    Cellsin human small intestinal organoids

More on p53–p21 pathway

Myofibroblast transformation

upin rat cells1

1 study
  1. Cisplatin induces myofibroblast transformation in rat cells (repeated administration of low-dose cisplatin (RAC)).

    Cellsrepeated administration of low-dose cisplatin (RAC)kidney fibroblasts

Myofibroblast activation

upin human cells1

1 study
  1. Cisplatin induces myofibroblast activation in human cells (supernatant collected from cisplatin-treated tubuloids).

    Cellssupernatant collected from cisplatin-treated tubuloids

DNA damage response

upin human cells1

1 study
  1. Cisplatin activates DNA damage response in human cells (cisplatin exposure).

    Cellscisplatin exposure

More on DNA damage response

Acute kidney injury

upin mice1

1 study
  1. Cisplatin increases acute kidney injury in aging vs young mice.

    Animalsin aging vs young micekidney

More on Acute kidney injury

Telomere length

no changein humans1

1 study
  1. Cisplatin showed no clear effect on telomere length in humans (5.7 (2.2-13.4) vs. 5.8 kb (1.6-19.2), P = 0.335).

    Human trialleukocyte1 yearn = 55

More on Telomere length

P53

upin human cells1

1 study
  1. Cisplatin increases P53 in HPV16+ head and neck cancer cell lines.

    Cellsin HPV16+ head and neck cancer cell lines

More on P53

Hematopoietic dysfunction

upin mice1

1 study
  1. Cisplatin increases hematopoietic dysfunction in PcnaK164R/K164R mice.

    Animalsin PcnaK164R/K164R micebone marrow

What is cisplatin linked with?

2

Studies link cisplatin with 2 measures: hearing function and frailty.

Hearing function

downin humans1

1 study
  1. Cisplatin is associated with hearing function in humans (head and neck cancer; dose-dependent association).

    Humanshead and neck cancer; dose-dependent associationn = 316

    Older patients had hearing loss at lower chemotherapy doses

    Cancer medicine

Frailty

upin humans1OR 3.93

1 study
  1. Cisplatin is linked with a higher risk of frailty in humans (childhood cancer survivors) (OR 3.93 (95% CI 1.45-10.67)).

    Humanschildhood cancer survivors>= 600 mg/m2n = 2,003

Trial sponsors

Funding

1 grant since 2021

National Institute of Diabetes and Digestive and Kidney Diseases$1.7M

Latest

Dec 2025: 5Jan 2026: 5Feb 2026: 8Mar 2026: 5Apr 2026: 0May 2026: 2Jun 2026: 6Jul 2026: 7Aug 2026: 4Sep 2026: 0Oct 2026: 9Nov 2026: 657 papers in 12 months
Research Square

Compound preserved ovarian follicles in injured and aged mice

Ten-month-old mice treated for two weeks retained more follicles than controls; separate cisplatin experiments found larger litters with co-treatment than with cisplatin…Ten-month-old mice treated for two weeks retained more follicles than controls; separate cisplatin experiments found larger litters with co-treatment than with cisplatin alone.

Preprint: mouse studyReproductive system

See all 200 papers on cisplatin